Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | neuroendocrine convertase 2 | 0.0596 | 0.4087 | 0.0526 |
Trichomonas vaginalis | Clan SB, family S8, subtilisin-like serine peptidase | 0.0576 | 0.3758 | 0.5 |
Trichomonas vaginalis | Clan SB, family S8, subtilisin-like serine peptidase | 0.0576 | 0.3758 | 0.5 |
Echinococcus multilocularis | neuroendocrine convertase 2 | 0.0596 | 0.4087 | 0.1038 |
Schistosoma mansoni | subfamily S8B unassigned peptidase (S08 family) | 0.0948 | 1 | 1 |
Loa Loa (eye worm) | endoprotease bli-4 | 0.0948 | 1 | 1 |
Brugia malayi | celfurPC protein | 0.0764 | 0.6922 | 0.4795 |
Echinococcus granulosus | furin | 0.0948 | 1 | 1 |
Giardia lamblia | High cysteine membrane protein Group 2 | 0.0352 | 0 | 0.5 |
Echinococcus multilocularis | 0.0764 | 0.6922 | 1 | |
Loa Loa (eye worm) | hypothetical protein | 0.0948 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC2x (functional) | > 1000 uM | Concentration of drug giving a 2-fold increase of the magnitude of the current induced by Ionotropic glutamate receptor AMPA (30 microM) and measured in Xenopus Oocytes expressing Rat Cortex AMPA Receptors | ChEMBL. | 9685234 |
EC2x (functional) | > 1000 uM | Concentration of drug giving a 2-fold increase of the magnitude of the current induced by Ionotropic glutamate receptor AMPA (30 microM) and measured in Xenopus Oocytes expressing Rat Cortex AMPA Receptors | ChEMBL. | 9685234 |
EC5X (functional) | > 1000 uM | concentration of drug giving a 5-fold increase of the magnitude of the current induced by Ionotropic glutamate receptor AMPA (30 microM) and measured in Xenopus Oocytes expressing Rat Cortex AMPA Receptors | ChEMBL. | 9685234 |
EC5X (functional) | > 1000 uM | concentration of drug giving a 5-fold increase of the magnitude of the current induced by Ionotropic glutamate receptor AMPA (30 microM) and measured in Xenopus Oocytes expressing Rat Cortex AMPA Receptors | ChEMBL. | 9685234 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.